Friday May 4 | The Motley Fool
ISTA Pharmaceuticals Posts a Surprise Profit
The 10-second takeaway For the quarter ended March 31 , ISTA Pharmaceuticals whiffed on revenues and beat expectations on earnings per share.
Bausch + Lomb to Acquire ISTA Pharmaceuticals
Bausch + Lomb and ISTA Pharmaceuticals announced that they have signed a definitive agreement under which Bausch + Lomb will acquire ISTA for $500 million.
FTC clears Bausch & Lomb's deal for ISTA Pharma
NEW YORK — Antitrust regulators have completed their review of Bausch & Lomb's acquisition of ISTA Pharmaceuticals Inc.
RLPC: Bausch & Lomb launches $3.485B credit
Bausch and Lomb has set price talk on its $3.485 billion cross-border loan, which was launched today by Citigroup, sources told Thomson Reuters LPC.